铁平衡改变和勃起功能障碍:勃起功能障碍治疗的新问题?
Claudio Marino1, Salvatore Iaconis2, Francesco Di Bello3
1Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, Naples. marinoclaudio88@outlook.it.
概括
在全球范围内,勃起功能障碍 (ED) 影响着大约50%的40-70岁男性. 这种常见的疾病源于心理,荷尔蒙和身体因素的复杂混合.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 安德罗学与人类学
- 男人的健康 男人健康
背景情况:
- 勃起功能障碍 (ED) 是一个广泛的全球健康问题,影响男性.
- 它的患病率随着年龄的增长而增加,估计影响了40至70岁之间的50%的男性.
- 对于受影响的个人来说,ED带来了重大的心理和社会负担.
研究的目的:
- 探索勃起功能障碍的多因素病因.
- 要突出导致ED的因素的复杂相互作用.
- 提供关于ED原因的当前理解的全面概述.
主要方法:
- 关于勃起功能障碍研究的文献综述.
- 对ED患病率的流行病学数据的分析.
- 综合研究ED的生理和心理基础.
主要成果:
- 勃起功能障碍是由心理,激素,神经,血管和结构因素的复杂相互作用造成的.
- 患病率数据表明,男性人口中很大一部分经历了ED.
- 勃起障碍的多因素性质需要采用整体方法来了解其原因.
结论:
- 勃起功能障碍是一种复杂的疾病,具有多种不同的促成因素.
- 了解这些因素的相互作用对于有效的诊断和治疗至关重要.
- 需要进一步的研究,以充分阐明ED背后的机制.
相关概念视频
Disorders of the Male Reproductive System
416
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
416
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
158
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
158
Infertility in Males
264
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
264
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
Male Sexual Response: Erection & Ejaculation
2.3K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
2.3K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
165
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
165


